Degree of modulation of cell-surface CD3 by anti-lymphocyte therapies
Affiliations
- PMID: 1824886
Item in Clipboard
Degree of modulation of cell-surface CD3 by anti-lymphocyte therapies
Transplant Proc.
1991 Feb.
No abstract available
Similar articles
-
In situ antigenic modulation of human graft-infiltrating T cells is induced by OKT3 treatment.Transplant Proc. 1990 Aug;22(4):1782. Transplant Proc. 1990. PMID: 2143860 No abstract available.
-
OKT3 vs ALG induction therapy in combined pancreas-kidney transplantation.Transplant Proc. 1991 Feb;23(1 Pt 2):1581-2. Transplant Proc. 1991. PMID: 1846478 No abstract available.
-
OKT3 for induction immunosuppression in renal transplantation: a comparative study of high versus low doses.Transplant Proc. 1991 Feb;23(1 Pt 2):1052-4. Transplant Proc. 1991. PMID: 1846453 No abstract available.
-
An overview of the use of the monoclonal antibody OKT3 in renal transplantation.Transplant Proc. 1988 Dec;20(6):1248-52. Transplant Proc. 1988. PMID: 2974204 Review.
-
Mechanisms of immunosuppression induced by antithymocyte globulins and OKT3.J Heart Lung Transplant. 1996 May;15(5):435-42. J Heart Lung Transplant. 1996. PMID: 8771497 Review.
Cited by
-
TGN1412 Induces Lymphopenia and Human Cytokine Release in a Humanized Mouse Model.PLoS One. 2016 Mar 9;11(3):e0149093. doi: 10.1371/journal.pone.0149093. eCollection 2016. PLoS One. 2016. PMID: 26959227 Free PMC article.
-
Phase I trial of a humanized, Fc receptor nonbinding anti-CD3 antibody, hu12F6mu in patients receiving renal allografts.MAbs. 2010 Jul-Aug;2(4):449-56. doi: 10.4161/mabs.12305. Epub 2010 Jul 1. MAbs. 2010. PMID: 20519962 Free PMC article. Clinical Trial.